Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)
Agency: National Institutes of Health
- 93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research
Forecasted opportunityLast Updated: Aug 20, 2026
Important dates
- Forecasted post date: December 1, 2026
- Forecasted application due date: February 10, 2027
- Forecasted award date: November 1, 2027
- Forecasted project start date: December 1, 2027
- Fiscal Year: 2028
Award details
- Expected project funding: $5,000,000
- Expected awards: 1
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:RFA-DK-28-116
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Forecast posted date: August 20, 2026
- Archive date: Not specified
- Version: 1
Summary
Type 1 diabetes (T1D) is a complex disease involving interactions among many different cell types, tissues, organs and biological processes. Genetics, the environment, and lifestyle all play a role in disease development and progression. Over the past two decades, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has supported major T1D research consortia covering basic, translational, and clinical research. Each consortium has focused on different aspects of T1D, such as specific organs, stages of disease or clinical outcomes. Together, these consortia have collected large longitudinal and multimodal datasets using standardized protocols and coordinated studies. While individual consortia have improved our understanding of specific areas, combining their work offers a rare opportunity to see how different biological processes interact to drive T1D development and progression. This integrated view can answer fundamental questions about T1D biology that cannot be answered using individual datasets or studies alone.
Recent advances in artificial intelligence (AI) now make it possible to integrate these complementary datasets and study T1D across various tissues, disease stages, and biological levels. Building on these resources, NIDDK will support a coordinated, milestone-driven research project to answer fundamental questions about T1D biology and accelerate the development of personalized medicine.
The project will combine multimodal human pancreas and clinical datasets to better understand how biological processes interact as T1D develops and progresses. The research will generate new insights into T1D biology, help us understand the different forms and stages of T1D, identify biomarkers, and inform new approaches for disease prevention, intervention, and treatment. To support the research, the project will develop and test advanced multimodal AI models. It will also develop AI-enabled research workflows, new methods to integrate data, and privacy-preserving synthetic datasets.
Eligibility
Business
- Small businesses
- For-profit organizations other than small businesses
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
Government
- Public and Indian housing authorities
- City or township governments
- State governments
- Special district governments
- County governments
- Federally recognized Native American tribal governments
Miscellaneous
- Other
Education
- Public and state institutions of higher education
- Private institutions of higher education
- Independent school districts
Additional information on eligibility
Documents
No documents are currently available.
Agency contact information
Email: NIDDK_DEM@nih.gov
NIDDK_DEM@nih.gov
Link to additional information
No additional information is available
